Several new and returning films found success at the global box office this past weekend. Tim Burton’s comedy sequel Beetlejuice Beetlejuice maintained its lead in its second week of release. The film earned an additional $80 million worldwide between Friday and Sunday. Its total global ticket sales now stand at $264 million after 10 days in theaters.
Beetlejuice Beetlejuice saw attendance drop 53% domestically but held strong internationally with a 44% decrease. The movie continues attracting large audiences worldwide. Britain remains its top market outside North America with $19 million in sales so far. Mexico and Spain have also contributed to the film’s robust global numbers. It debuted atop box office charts in both France and Germany this weekend.
The psychological horror remake Speak No Evil also premiered to solid ticket sales. Directed by James Watkins, the film stars James McAvoy and Mackenzie Davis. It generated $11.5 million in the United States and $9.3 million in 72 additional countries for a global debut total of $20.8 million.
The UK followed the U.S. as the second biggest market, likely boosted by Scottish actor James McAvoy’s leading role. With a $15 million production budget and decent reviews from audiences, the film looks poised for profits as it continues release internationally.
In South Korea, the local crime thriller Veteran 2: I, The Executioner made an impressive domestic debut of $15.1 million. The sequel reunited director Ryoo Seung-wan with star Hwang Jung-min and benefited from the multi-day Chuseok holiday. Its launch ranks as the second largest Korean opening of 2022.
Established hits like Deadpool & Wolverine, Stand By Me, and The Greatest Of All Time also contributed to ticket sales around the world last weekend alongside the new releases. Beetlejuice Beetlejuice aims to sustain momentum against upcoming films, as Speak No Evil strives for success in the competitive horror genre space. Veteran 2’s result highlights the ongoing strength of local content in important international markets.